User login
Key clinical point: Among pediatric patients with pancreatic neoplasms who underwent pancreatic surgery, exocrine pancreatic insufficiency (EPI) occurred early after surgery but did not affect growth course with prompt treatment. Endocrine failure was less common and developed later, highlighting the need for long-term monitoring in this patient population.
Major finding: EPI occurred in 25% of patients within 6 months after surgery, and endocrine failure developed in 12.5% of patients 8-10 years after surgery. All patients with EPI required pancrelipase supplementation. No significant difference was observed in the body mass index z-score at diagnosis vs. the last follow-up.
Study details: This retrospective study included 16 pediatric patients with pancreatic neoplasms who underwent pancreatic surgery (pancreaticoduodenectomy, 50%).
Disclosures: No source of funding was identified. The authors declared no conflict of interests.
Source: Bolasco G et al. World J Clin Cases. 2021;9(25):7340-7349. doi: 10.12998/wjcc.v9.i25.7340.
Key clinical point: Among pediatric patients with pancreatic neoplasms who underwent pancreatic surgery, exocrine pancreatic insufficiency (EPI) occurred early after surgery but did not affect growth course with prompt treatment. Endocrine failure was less common and developed later, highlighting the need for long-term monitoring in this patient population.
Major finding: EPI occurred in 25% of patients within 6 months after surgery, and endocrine failure developed in 12.5% of patients 8-10 years after surgery. All patients with EPI required pancrelipase supplementation. No significant difference was observed in the body mass index z-score at diagnosis vs. the last follow-up.
Study details: This retrospective study included 16 pediatric patients with pancreatic neoplasms who underwent pancreatic surgery (pancreaticoduodenectomy, 50%).
Disclosures: No source of funding was identified. The authors declared no conflict of interests.
Source: Bolasco G et al. World J Clin Cases. 2021;9(25):7340-7349. doi: 10.12998/wjcc.v9.i25.7340.
Key clinical point: Among pediatric patients with pancreatic neoplasms who underwent pancreatic surgery, exocrine pancreatic insufficiency (EPI) occurred early after surgery but did not affect growth course with prompt treatment. Endocrine failure was less common and developed later, highlighting the need for long-term monitoring in this patient population.
Major finding: EPI occurred in 25% of patients within 6 months after surgery, and endocrine failure developed in 12.5% of patients 8-10 years after surgery. All patients with EPI required pancrelipase supplementation. No significant difference was observed in the body mass index z-score at diagnosis vs. the last follow-up.
Study details: This retrospective study included 16 pediatric patients with pancreatic neoplasms who underwent pancreatic surgery (pancreaticoduodenectomy, 50%).
Disclosures: No source of funding was identified. The authors declared no conflict of interests.
Source: Bolasco G et al. World J Clin Cases. 2021;9(25):7340-7349. doi: 10.12998/wjcc.v9.i25.7340.